Swedbank Robur
VC Fund
Stockholm, Sweden
Swedbank Robur is a small, equity-based mutual fund that provides in largest asset managers and a strong investment partner.
- Total investments:
- 27
- Last investment:
- Lead investor:
- 56%
Last updated:
For AI agents: llms.txt
Industries Swedbank Robur invests in
Stages Swedbank Robur invests in
Countries Swedbank Robur invests in
Round sizes
Round size
- Series B
- $8.9M–$190M
- Post-IPO Equity
- $2.3M–$230M
Investment Focus
Industry
- Health Care 4 (15%)
- Manufacturing 4 (15%)
- Mobile Apps 3 (11%)
- Apps 2 (7%)
- Medical 2 (7%)
Stage
- Post-IPO Equity 6 (22%)
- Series B 4 (15%)
- Funding Round 4 (15%)
- Venture - Series Unknown 4 (15%)
- Series C 2 (7%)
Country
- Sweden 15 (56%)
- United States 2 (7%)
- Norway 1 (4%)
- Germany 1 (4%)
- United Kingdom 1 (4%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Catena
|
Catena is a listed property company that, through collaboration sustainably develops, owns and manages efficient logistics facilities. Its strategically located properties supply the Scandinavian metropolitan areas and are adapted for both current and future goods flows. | $204.9M / Post-IPO Equity / Mar 12, 2024 | |
Northvolt
|
Northvolt develops sustainable lithium-ion batteries in conjunction with R&D, industrialization, and recycling to support clean energy. It provides electrification and renewable energy storage designed for lithium-ion battery plant to produce batteries for electric vehicles. Northvolt's product is an environment-friendly batterymanufactured with minimal carbon footprint and with recycling technology without compromising with important eco-systems, enabling the auto industry to replace fossil fuels with electricity in an efficient manner. The company aims to establish a supply of sustainable battery cells and systems.In 2016, Paolo Cerruti and Peter Carlsson headquartered the company in Stockholm, Stockholms Lan. | $1.2B / Convertible Note / Aug 22, 2023 | |
Vicore Pharma
|
Vicore Pharma is a pharmaceutical company dedicated to developing innovative medicines for severe lung disorders. It develops drugs that act through the AT2 receptor. The company’s drug candidate C21 aims to improve the treatment of idiopathic pulmonary fibrosis, a rare disease for which C21 has been granted orphan drug designation both in the EUand the US. In addition, C21 is explored pre-clinically in a number of rare diseases where the AT2 receptor plays an important role. The company is based in Astra Zeneca’s Bioventurehub in Mölndal. | $46.2M / Post-IPO Equity / Jun 09, 2023 | |
Anocca
|
Anocca AB provides services like Biotechnology, Immunotherapeutics, Drug Discovery, Drug Development, Immunology. | $36.9M / Venture - Series Unknown / May 31, 2023 | |
Dignitana
|
Dignitana AB clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. | $2.3M / Post-IPO Equity / Oct 18, 2022 | |
Stegra
|
H2 Green Steel helps to build a large-scale steel factory based on a fossil-free manufacturing process targeting large European OEMs.The plant will be built in northern Sweden, in Boden, offering unique conditions for cost-competitive fossil-free steel production. The project includes a giga-scale green hydrogen plant as an integrated part of thesteel production facility. Production will begin in 2024 and by 2030, H2GS will have an annual production capacity of five million tons of high-quality steel. | $190.2M / Series B / Aug 29, 2022 | |
Instabox
|
Instabox Express is a shipping service available in selected online stores. It ship your express delivery package to our lockers in Sweden, Norway and Denmark.Instabox handles logistics for e-commerce retailers, offering same-day delivery through its network of last-mile smart delivery lockers. The service reaches about six million Swedes,delivering from the likes of H&M, Ikea, and Lloyds. In a press release, the company claims its growth has more than tripled each year over the last few years. | $9.5M / Convertible Note / Jul 07, 2022 | |
|
Northvolt
|
Northvolt develops sustainable lithium-ion batteries in conjunction with R&D, industrialization, and recycling to support clean energy. It provides electrification and renewable energy storage designed for lithium-ion battery plant to produce batteries for electric vehicles. Northvolt's product is an environment-friendly batterymanufactured with minimal carbon footprint and with recycling technology without compromising with important eco-systems, enabling the auto industry to replace fossil fuels with electricity in an efficient manner. The company aims to establish a supply of sustainable battery cells and systems.In 2016, Paolo Cerruti and Peter Carlsson headquartered the company in Stockholm, Stockholms Lan. | $1.1B / Grant / Jul 05, 2022 | |
|
Northvolt
|
Northvolt develops sustainable lithium-ion batteries in conjunction with R&D, industrialization, and recycling to support clean energy. It provides electrification and renewable energy storage designed for lithium-ion battery plant to produce batteries for electric vehicles. Northvolt's product is an environment-friendly batterymanufactured with minimal carbon footprint and with recycling technology without compromising with important eco-systems, enabling the auto industry to replace fossil fuels with electricity in an efficient manner. The company aims to establish a supply of sustainable battery cells and systems.In 2016, Paolo Cerruti and Peter Carlsson headquartered the company in Stockholm, Stockholms Lan. | $1B / Convertible Note / Jul 05, 2022 | |
Babylon
|
Babylon is a digital-first, value-based care company. Founded in 2013, it aims to make high-quality healthcare accessible and affordable for everyone on Earth. It reengineers the global healthcare market to better align system-wide incentives and to shift the focus from reactive sick care to preventative healthcare, resulting in better memberhealth, improved member experience and reduced costs. To achieve this goal, it leverages its highly scalable, digital-first platform combined with high quality clinical operations and affiliated provider networks to provide an integrated, end-to-end healthcare solution. | $230M / Post-IPO Equity / Oct 22, 2021 | |
| See all 27 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Swedbank Robur invest in?
Swedbank Robur invests primarily in Health Care, Manufacturing and Mobile Apps startups, most often at Post-IPO Equity and Series B stage. Most of the 27 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Swedbank Robur's check size?
Swedbank Robur typically joins rounds of $8.9M–$190M at Series B and $2.3M–$230M at Post-IPO Equity. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Swedbank Robur participates in.
When did Swedbank Robur last invest?
The most recent investment recorded for Swedbank Robur closed in Mar 2024. Shizune tracks 27 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
